Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2–6 in Chicago. The event will feature plenary, oral abstract, education, and special sessions in both in-person and online meeting formats.
MSK experts will be available to comment on their high-profile research on topics such as brain cancer, ovarian cancer, rectal cancer, and more:
- Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, will present significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.
- Deb Schrag, MD, MPH, gastrointestinal oncologist and Chair of the Department of Medicine, will present results from a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total surgical excision for the treatment of patients with locally advanced rectal cancer.
- Carol Aghajanian, MD, gynecologic oncologist and Chief of the Gynecologic Medical Oncology Service, will highlight results from a phase III trial that found that a maintenance therapy resulted in improved outcomes as a first-line treatment in patients with advanced ovarian cancer.
In addition, as part of the 2023 Annual Meeting, several MSK physician-scientists have been honored with prestigious awards by ASCO, including:
- Deb Schrag, MD, MPH, received the ASCO-American Cancer Society Cancer Prevention Award, which recognizes significant contributions to cancer prevention and control research or practice. Dr. Schrag is internationally recognized as a pioneer for her work engaging patients in reporting outcomes to advance care. Her work has focused specifically on improving the delivery, quality, and effectiveness of cancer care.
- Three MSK researchers received the 2023 Career Development Awards (CDA) by Conquer Cancer: Nour Abuhadra, MD, breast oncologist; Ivan Kotchetkov, MD, neurologist and neuro-oncologist; and Winston Wong, MD, head and neck oncologist. The CDA provides three years of research funding to clinical investigators in the first to third year of faculty appointment to establish an independent clinical cancer research program.
- Several MSK researchers received the 2023 Young Investigator Award (YIA) by Conquer Cancer: Duaa Al-Rawi, MD, PhD, medical oncology/hematology fellow; Monica Chen, MD, medical oncology/hematology fellow; Philip Choi, MD, PhD, medical oncology/hematology fellow; Samuel Cytryn, MD, medical oncology/hematology fellow; Arielle Elkrief, MD, research fellow; Emily Harrold, MBBCh, BAO, MRCP, advanced oncology fellow; Justin Jee, MD, PhD, medical oncology/hematology fellow; Andrew Katims, MD, MPH, urologic oncology fellow; Fergus Keane, MB BCh, BAO, advanced oncology fellow; Yonit Lavin, MD, PhD, medical oncology/hematology fellow; Xiaoli Mi, MD, medical oncology/hematology fellow; Patricia Mae Garcia Santos, MD, MS, radiation oncology resident; Brian Shinder, MD, urologic oncology fellow; Anupriya Singhal, MD, PhD, medical oncology/hematology fellow; Robert Stanley, MD, PhD, medical oncology/hematology fellow; Jane Sze Yin Sui, MBBCh BAO, MRCP, medical oncology/hematology fellow; Rohit Thummalapalli, MD, medical oncology/hematology fellow; and Jennifer Tsai, MD, PhD, medical oncology/hematology fellow. The YIA provides research funding to promising young physicians during the final years of training to support the transition to a faculty appointment and to encourage quality research in clinical oncology.
- Several MSK researchers received the 2023 Annual Meeting Merit Awards by Conquer Cancer: Alexander Boardman, MD, medical oncology/hematology fellow; Monica Chen, MD, medical oncology/hematology fellow; Edward Dee, MD, resident physician; Emily Harrold, MBBCh, BAO, MRCP, advanced oncology fellow; Justin Jee, MD, PhD, medical oncology/hematology fellow; Fergus Keane, MB BCh, BAO, advanced oncology fellow; Samyukta Mullangi, MD, MBA, medical oncology/hematology fellow; Kirin Saint, Integrative Medicine research fellow; Patricia Mae Garcia Santos, MD, MS, radiation oncology resident; James Smithy, MD, MHS, medical oncology/hematology fellow; and Floris Verheij, BSc, graduate research assistant. Merit Awards recognize oncology trainees and students whose research is addressed in high-quality abstracts submitted to the ASCO Annual Meeting and recognized for their scientific merit.
For more information and to set up interviews with MSK experts, contact John Connolly, Director of Media Relations, at [email protected]. Follow the meeting live on Twitter using the hashtag #ASCO23 and follow MSK on Twitter at @MSKCancerCenter.